Marshall Wace North America’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.95M Buy
+30,085
New +$1.84M 0.01% 729
2021
Q2
Sell
-88,768
Closed -$4.78M 1662
2021
Q1
$4.78M Buy
+88,768
New +$4.83M 0.02% 580
2020
Q4
Sell
-7,025
Closed -$275K 1491
2020
Q3
$275K Buy
+7,025
New +$256K ﹤0.01% 1082
2020
Q2
Sell
-113,722
Closed -$3.85M 1372
2020
Q1
$3.85M Buy
+113,722
New +$4.55M 0.03% 362
2019
Q4
Sell
-105,000
Closed -$5.23M 1495
2019
Q3
$5.23M Buy
+105,000
New +$5.36M 0.03% 355
2019
Q2
Sell
-152,401
Closed -$8.04M 1464
2019
Q1
$8.04M Buy
152,401
+71,188
+88% +$3.71M 0.06% 241
2018
Q4
$3.82M Buy
81,213
+11,657
+17% +$608K 0.04% 292
2018
Q3
$4.01M Sell
69,556
-12,922
-16% -$715K 0.03% 362
2018
Q2
$4.49M Buy
82,478
+77,818
+1,670% +$3.86M 0.03% 542
2018
Q1
$220K Buy
+4,660
New +$233K ﹤0.01% 1320

Other funds holding NTR

Marshall Wace North America's NTR Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Nutrien (NTR) in Q3 2021: 30,085 shares worth $1.95M. The stake represents 0.01% of the portfolio and ranks #729 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in NTR as recently as Q1 2021.

Marshall Wace North America first reported a position in NTR in Q1 2018 and has held it in 10 quarters since. The position peaked at $8.04M in Q1 2019. 588 funds tracked by Wall St. Rank hold NTR as of Q3 2021.

  • Marshall Wace North America held 30,085 shares of Nutrien worth $1.95M as of Q3 2021.
  • Nutrien was a new Marshall Wace North America position in Q3 2021.
  • Nutrien made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #729 holding.
  • Marshall Wace North America first reported a position in Nutrien in Q1 2018 and has held it in 10 quarters since.
  • Marshall Wace North America's Nutrien position peaked at $8.04M in Q1 2019.
  • 588 funds tracked by Wall St. Rank held Nutrien as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.